Skip to main navigation

Skip to Content

About
Overview
News & Events
- News Releases
- Events & Presentations
Financial Reports
Stock Info
Analyst Coverage
Corporate Governance
Investor Resources
- Email Alerts
- Contact Us

Events & Presentations

Events & Presentations

Presentations

TK216 FOR RELAPSED/REFRACTORY EWING SARCOMA-INTERIM PHASE 1/2 RESULTS VIDEO

Lee ASCO poster should be: Phase 1/2 Study of Cirmtuzumab and Ibrutinib in Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia (CLL)

Lee ASCO poster should be: Phase 1/2 Study of Cirmtuzumab and Ibrutinib in Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia (CLL) VIDEO

TK216 FOR RELAPSED/REFRACTORY EWING SARCOMA-INTERIM PHASE 1/2 RESULTS

Corporate Presentation, May 2021

Shatsky 2021 AACR Poster Cirmtuzumab HER2-neg Breast

Upcoming Events

More events are coming soon.

Past Events

Jefferies Virtual Healthcare Conference

Jun 3, 2021 at 10:30 AM EDT

Click here for webcast

Q1 2021 Corporate Update and Financial Results Conference Call

May 6, 2021 at 5:00 PM EDT

Click here for webcast

© 2021 Oncternal Therapeutics, Inc. All rights reserved.